UHS — Universal Health Services, Inc. stock price, charts and financials
QT47Universal Health Services, Inc.Universal Health Services, Inc. (NYSE: UHS) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500 | P/E | 6.93 | EPS (ttm) | 24.21 | Insider Own | 8.86% | Shs Outstand | 60.54M | Perf Week | 0.99% |
| Market Cap | 10.16B | Forward P/E | 6.94 | EPS next Y | 24.19 | Insider Trans | -0.01% | Shs Float | 50.39M | Perf Month | 6.21% |
| Enterprise Value | 15.29B | PEG | 1.62 | EPS next Q | 5.51 | Inst Own | - | Short Float | 6.75% | Perf Quarter | 1.08% |
| Income | 1.53B | P/S | 0.56 | EPS this Y | -6.54% | Inst Trans | - | Short Ratio | 3.32 | Perf Half Y | -16.84% |
| Sales | 18.11B | P/B | 1.33 | EPS next Y | 6.92% | ROA | 9.58% | Short Interest | 3.40M | Perf YTD | -23.00% |
| Book/sh | 126.45 | P/C | 73.11 | EPS next 5Y | 4.27% | ROE | 20.66% | 52W High | 246.32 -31.85% | Perf Year | 3.00% |
| Cash/sh | 2.30 | P/FCF | 12.33 | EPS past 3/5Y | 36.21% 16.02% | ROIC | 11.68% | 52W Low | 140.08 19.84% | Perf 3Y | 21.00% |
| Dividend Est. | 0.80 (0.48%) | EV/EBITDA | 5.42 | Sales past 3/5Y | 9.03% 8.48% | Gross Margin | 51.44% | Volatility | 3.79% 3.52% | Perf 5Y | 5.50% |
| Dividend TTM | 0.80 (0.48%) | EV/Sales | 0.84 | EPS Y/Y TTM | 43.94% | Oper. Margin | 11.36% | ATR (14) | 6.43 | Perf 10Y | 22.86% |
| Dividend Ex-Date | Sep 01, 2026 | Quick Ratio | 1.04 | Sales Y/Y TTM | 14.44% | Profit Margin | 8.42% | RSI (14) | 63.83 | Recom | 2.67 |
| Dividend Gr. 3/5Y | 0.00% 31.95% | Current Ratio | 1.12 | EPS Q/Q | 11.78% | SMA20 | 7.05% | Beta | 1.04 | Target Price | 193.00 |
| Payout | 3.25% | Debt/Eq | 0.74 | Sales Q/Q | 8.26% | SMA50 | 10.85% | Rel Volume | 0.68 | Prev Close | 169.04 |
| Employees | 101,500 | LT Debt/Eq | 0.63 | Earnings | Oct 26 | SMA200 | -12.29% | Avg Volume | 1.07M | Price | 167.87 |
| IPO Date | Jul 09, 1981 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 0.67% 1.29% | Net Debt/EBITDA | 1.82 | Volume | 732,933 | Change | -0.69% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-03-26 | Reiterated | RBC Capital | Sector Perform | $190 → $183 |
| Jul-30-26 | Reiterated | Goldman Sachs | Neutral | $219 → $190 |
| Jul-29-26 | Reiterated | UBS | Buy | $310 → $290 |
| Jul-29-26 | Reiterated | Robert W. Baird | $204 → $166 | |
| Jul-29-26 | Reiterated | Guggenheim | Buy | $195 → $189 |
| Jul-29-26 | Reiterated | Morgan Stanley | Equal Weight | $233 → $191 |
| Jul-28-26 | Reiterated | Barclays | Equal Weight | $179 → $168 |
| Jul-20-26 | Reiterated | Guggenheim | Buy | $211 → $195 |
| Jul-13-26 | Reiterated | Wells Fargo | Equal Weight | $165 → $166 |
| Jul-08-26 | Downgrade | Barclays | Overweight → Equal Weight | $238 → $179 |
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 18,114 | 17,365 | 15,828 | 14,282 | 13,399 | 12,642 | 11,559 | 11,378 | 10,772 | |
| Cost of Goods Sold Incl. D&A | 8,796 | 1,659 | 1,588 | 1,533 | 1,474 | 1,427 | 1,288 | 1,251 | 1,169 | |
| Gross Profit | 9,319 | 15,706 | 14,240 | 12,749 | 11,925 | 11,215 | 10,271 | 10,127 | 9,604 | |
| Selling, General and Administrative Excl. Other | 4,195 | 8,233 | 7,665 | 7,249 | 6,894 | 6,283 | 5,729 | 5,697 | 5,361 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 3,065 | 5,479 | 4,893 | 4,325 | 4,027 | 3,569 | 3,183 | 3,214 | 3,067 | |
| Operating Income | 2,059 | 1,994 | 1,682 | 1,175 | 1,004 | 1,363 | 1,358 | 1,216 | 1,175 | |
| Interest Expense | 155 | 157 | 188 | 207 | 127 | 85 | 109 | 163 | 155 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 124 | 135 | 4 | -28 | -10 | 15 | 3 | 13 | 14 | |
| Net Income Before Taxes | 2,026 | 1,972 | 1,498 | 940 | 866 | 1,293 | 1,252 | 1,066 | 1,035 | |
| Income Taxes | 477 | 461 | 335 | 221 | 209 | 306 | 299 | 239 | 237 | |
| Consolidated Net Income | 1,526 | 1,489 | 1,142 | 718 | 676 | 992 | 944 | 815 | 780 | |
| Net Income From Continuing Operations | 1,551 | 1,511 | 1,163 | 719 | 657 | 988 | 953 | 828 | 798 | |
| Net Income | 1,526 | 1,489 | 1,142 | 718 | 676 | 992 | 944 | 815 | 780 | |
| EPS (Recurring) | 24.52 | 23.42 | 17.16 | 10.35 | 9.23 | 11.99 | 11.06 | 9.16 | 8.36 | |
| EPS (Basic, Before Extraordinaries) | 24.52 | 23.42 | 17.16 | 10.35 | 9.23 | 11.99 | 11.06 | 9.16 | 8.36 | |
| EPS (Diluted) | 24.21 | 23.10 | 16.82 | 10.23 | 9.14 | 11.82 | 10.99 | 9.13 | 8.32 | |
| EBITDA | 2,821 | 2,743 | 2,265 | 1,715 | 1,575 | 1,910 | 1,869 | 1,719 | 1,635 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 6.93 | 9.44 | 10.67 | 14.90 | 15.41 | 10.97 | 12.51 | 15.71 | 14.01 | |
| Price To Sales Ratio | 0.57 | 0.80 | 0.76 | 0.74 | 0.77 | 0.85 | 1.01 | 1.12 | 1.01 | |
| Gross Margin | 51.45 | 90.45 | 89.97 | 89.27 | 89.00 | 88.71 | 88.86 | 89.01 | 89.16 | |
| Operating Margin | 11.37 | 11.48 | 10.63 | 8.23 | 7.49 | 10.78 | 11.75 | 10.69 | 10.91 | |
| Net Margin | 8.42 | 8.57 | 7.22 | 5.03 | 5.05 | 7.85 | 8.17 | 7.16 | 7.24 | |
| Shares Outstanding | 61 | 64 | 67 | 69 | 73 | 83 | 85 | 89 | 93 | |
| Market Capitalization | 10,240 | 13,953 | 12,021 | 10,518 | 10,285 | 10,762 | 11,688 | 12,768 | 10,840 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| SUSSMAN ELLIOT J MD MBA | Director | Mar 13 '26 | Option Exercise | 138.80 | 1,250 | 173,500 | 7,363 | Mar 13 |
| SUSSMAN ELLIOT J MD MBA | Director | Mar 13 '26 | Sale | 193.37 | 356 | 68,841 | 6,113 | Mar 13 |
| Singer Maria Ruderman | Director | Mar 12 '26 | Option Exercise | 138.80 | 2,500 | 347,000 | 10,384 | Mar 13 |
| Miller Marc D | President and CEO | Mar 12 '26 | Option Exercise | 145.77 | 100,425 | 14,638,889 | 411,721 | Mar 13 |
| FILTON STEVE | Executive Vice President & CFO | Mar 12 '26 | Option Exercise | 146.14 | 83,237 | 12,164,529 | 201,738 | Mar 13 |
| SUSSMAN ELLIOT J MD MBA | Director | Mar 11 '26 | Option Exercise | 138.80 | 1,250 | 173,500 | 1,250 | Mar 13 |
| SUSSMAN ELLIOT J MD MBA | Director | Mar 11 '26 | Sale | 186.35 | 318 | 59,258 | 6,113 | Mar 13 |
| MILLER ALAN B | Executive Chairman | Mar 10 '26 | Option Exercise | 146.14 | 132,712 | 19,394,968 | 1,878,743 | Mar 11 |
| Nimetz Warren J. | Director | Nov 11 '25 | Sale | 223.30 | 3,817 | 852,344 | 8,481 | Nov 12 |
| Nimetz Warren J. | Director | Nov 11 '25 | Option Exercise | 138.80 | 10,000 | 1,388,000 | 18,481 | Nov 12 |
| MILLER ALAN B | Executive Chairman | Oct 29 '25 | Option Exercise | 146.14 | 132,713 | 19,395,121 | 1,851,550 | Oct 30 |
| SUSSMAN ELLIOT J MD MBA | Director | Oct 29 '25 | Sale | 225.70 | 965 | 217,799 | 6,113 | Oct 30 |
| Peterson Matthew Jay | Executive Vice President, UHS | Oct 29 '25 | Option Exercise | 146.14 | 17,890 | 2,614,506 | 34,270 | Oct 30 |
| SUSSMAN ELLIOT J MD MBA | Director | Oct 29 '25 | Option Exercise | 138.80 | 2,500 | 347,000 | 8,613 | Oct 30 |
| Miller Marc D | President and CEO | Oct 29 '25 | Option Exercise | 146.37 | 165,000 | 24,151,200 | 443,054 | Oct 30 |